{
    "code": "02022212",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022212",
    "time": "2016-11-18 20:09:43",
    "許可證字號": "衛署藥輸字第022212號",
    "註銷狀態": "已註銷",
    "註銷日期": "96\/06\/12",
    "註銷理由": "國外藥廠確效未通過",
    "有效日期": "92\/06\/16",
    "發證日期": "87\/06\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202221204",
    "中文品名": "服舒兒內服液",
    "英文品名": "FUTSUNARON SYRUP-K",
    "適應症": "感冒諸症狀（鼻水、鼻塞、噴嚏、喉痛、咳嗽、惡寒、發熱、頭痛、關節疼痛、肌肉酸痛）之緩解。",
    "劑型": "170內服液劑",
    "包裝": "瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "17醫師藥師藥劑生指示藥",
    "主成分略述": [
        "DL-CHLORPHENIRAMINEMALEATE,ACETAMINOPHEN(EQTOPARACETAMOL),CAFFEINE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1603811100  熹樂企業有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F260113100  JPS PHARMACEUTICAL CO., LTD. (TOCHISI PLANT)",
        "製造廠廠址": "196-1 HAGADAI HAGA-TOWN HAGA-GUN TOCHIGI-PREF JAPAN",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400000813",
            "成分名稱": "DL-CHLORPHENIRAMINE MALEATE",
            "含量描述": "0.0416",
            "含量": "0.0416000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2808000100",
            "成分名稱": "ACETAMINOPHEN (EQ TO PARACETAMOL)",
            "含量描述": "6.25",
            "含量": "6.2500000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2820000400",
            "成分名稱": "CAFFEINE",
            "含量描述": "0.4166",
            "含量": "0.4166000000",
            "單位": "MG"
        }
    ]
}